CoViproteHCt

Identifying true markers of protective immunity will allow for the identification of individuals, in particular healthcare personnel working with COVID-19 patients and in other critical areas protected from re-infection


We are not yet sure how to define the protective immune response, which is necessary for vaccine development and to safely get people back to work.”

PROF Dr. Markus
Gerhard

Description of the Study:

  • Title: CoViproteHCt.
  • Principal investigator: Markus Gerhard.
  • Centers of Implementation: Technische Universität München (TUM), Fundacion Privada Instituto de Salud Global Barcelona (ISGLOBAL), the University of Barcelona and Mikrogen GmbH.
  • Study Population: Healthcare personnel who have tested positive for SARS CoV-2.
  • Methods: The project team will collect blood samples from healthcare personnel who have tested positive for SARS CoV-2 and follow their health status for 6 months. Their blood will be tested for various antibody markers that are currently being used by different research teams to develop assays for COVID-19 immunity. By comparing blood content with the actual health of the individuals involved, it will be possible to determine which types of assays measure truly protective immunity.

Objectives of the Study:

Principal Objective: To develop and validate assays to characterise protective immune responses that can be used to identify individuals with COVID-19 immunity.


More about this Study:

Identifying true markers of protective immunity will allow for the identification of individuals protected from re-infection. The primary beneficiaries would be healthcare personnel, who would know whether they are safe in environments with a high risk of exposure, and society will benefit from maintenance of a functioning healthcare workforce. Identifying the assays that truly determine immunity will also make it possible to allow large portions of the population to return to economic activity. In addition, the validated assays can be used in future vaccine trials, to determine the effectiveness of experimental vaccines.

Tumlogo
Ewhujgnxeaimkmk
Fxzhhemzsrpnjv7vuznf
Health


Other Studies about Immunology :

Effectiveness of vaccine combination

Científicos franceses demuestran que la vacunación primaria con dos vacunas diferentes sería más eficaz que la vacunación con dos vacunas idénticas.

The Social Perception Of COVID-19 Vaccines

This study conducted by the UOC aims to find out the opinion of the Spanish population and professional healthcare personnel on the COVID-19 vaccines.

CombivacS

Clinical trial designed to evaluate the safety and immunogenicity of a dose of Comirnaty vaccine (Pfizer) in people who have previously received a dose of Vaxcevria vaccine (AstraZeneca).

MOOD-COVID

MOOD-COVID aims to study the impact of the pandemic on the mental health of pregnant women, young mothers and their children.

Emotional State Of Adults In The Process Of Bereavement By COVID-19

This study aims to analyse the emotional and spiritual state of adults who have lost a loved one due to COVID-19.

E-speranza-COVID19 Project

This study aims to demonstrate efficacy of Montelukast for patients with persistent COVID-19 to help them improve their quality of life.

Early Corticosteroid Treatment for COVID-19

This study proposal aims to determine whether early corticosteroid treatment can reduce the need for oxygen therapy and post-COVID sequelae.

MINDCOVID: Mental Health in a Pandemic

This study aims to assess the mental health impact and needs associated with COVID-19 in Spain.

CIBERESUCI COVID

CIBERES UCI COVID is a fundamental study that will improve care of critical patients infected by COVID-19.

NAUTILUS Project

The NAUTILUS project aims to develop an artificial intelligence platform to identify, predict and intervene on persistent symptoms in people who have suffered from COVID-19.